
Optum Health is owned by UnitedHealth Group, Inc. (NYSE: UNH), a publicly traded American healthcare company headquartered in Minnetonka, Minnesota. Optum Health is UnitedHealth Group's healthcare delivery and value-based care division, employing or affiliating with more than 90,000 physicians across primary care, specialty care, urgent care, home health, and behavioral health. Optum Health generated revenues of $105.4 billion in fiscal year 2024, making it one of the largest healthcare delivery organizations in the United States.
Parent Company
Founded
2011
Status
Publicly Traded
Headquarters
| Brand | Parent Company | Ownership Type |
|---|---|---|
| Optum Health | UnitedHealth Group | Wholly owned |
Optum Health's origins trace to UnitedHealth Group's strategy of expanding beyond health insurance into direct healthcare delivery, which accelerated in the 2010s. UnitedHealth Group formed Optum as a consolidated health services platform in 2011, bringing together various healthcare services businesses under a single brand. Optum Health was established as the division responsible for direct patient care and healthcare delivery within this structure.
The foundation of Optum Health's physician network was built through a series of acquisitions of physician practice management companies and medical groups throughout the 2010s. UnitedHealth Group acquired Monarch HealthCare, a large physician group in California, and numerous other medical practices across the United States. These acquisitions gave Optum Health a substantial employed physician base and a network of primary care and specialty care clinics.
A transformative acquisition came in 2017 when UnitedHealth Group acquired DaVita Medical Group, the physician practice management division of DaVita, Inc., for approximately $4.9 billion. The DaVita Medical Group acquisition added approximately 300 medical clinics and 1,700 employed physicians to Optum Health's network, significantly expanding its presence in California, Nevada, Colorado, and other states.
Optum Health continued expanding its physician network through the late 2010s and early 2020s, acquiring additional medical groups and establishing new primary care clinics. The COVID-19 pandemic in 2020 accelerated the adoption of telehealth services, and Optum Health invested in virtual care capabilities to complement its physical clinic network.
By 2024, Optum Health had grown to employ or affiliate with more than 90,000 physicians, making it one of the largest physician employers in the United States. The New York Times reported in July 2024 that UnitedHealth Group, through Optum, employs or is affiliated with roughly 90,000 doctors, more than any other company in the United States. Optum Health's value-based care patient population grew by approximately 600,000 patients in 2024, reflecting continued expansion of its primary care and value-based care programs.
Optum Health's 2024 revenues of $105.4 billion, up 10.5 percent from 2023, reflect the division's continued growth through both organic expansion and acquisitions. The revenue figure includes both clinical services revenues and capitation payments received for managing the health of value-based care patient populations.
In 2024 and 2025, UnitedHealth Group faced significant challenges that affected Optum Health. The February 2024 Change Healthcare ransomware attack disrupted healthcare payments across the United States and cost the company approximately $2.9 billion in response costs. CEO Andrew Witty departed in May 2024 and was replaced by Stephen Hemsley. The Department of Justice increased scrutiny of UnitedHealth Group's vertical integration strategy, including its acquisition of physician practices through Optum Health.
Despite these challenges, Optum Health has continued to expand its physician network and value-based care programs. The division's growth strategy has focused on acquiring primary care practices, expanding into new geographic markets, and increasing its value-based care patient population. However, the pace of acquisitions has been affected by increased regulatory scrutiny of healthcare consolidation.
UnitedHealth Group operates through two primary platforms that work together to deliver comprehensive healthcare solutions: UnitedHealthcare and Optum. This integrated business model enables the company to serve the entire healthcare continuum, from insurance coverage to direct healthcare delivery and technology services, creating synergies that enhance both quality and efficiency.
UnitedHealthcare represents the company's health insurance and benefits division, providing coverage to individuals, employers, and government-sponsored programs including Medicare and Medicaid. In 2025, UnitedHealthcare served 49.8 million consumers and achieved revenues of $344.9 billion, representing 16% growth year-over-year. The division operates through multiple business segments including individual and family plans, employer-sponsored coverage, Medicare Advantage plans, and Medicaid managed care programs.
UnitedHealthcare's success stems from its extensive provider networks, innovative benefit designs, and focus on value-based care models. The company has developed sophisticated approaches to care coordination, preventive health programs, and chronic disease management that improve health outcomes while managing costs effectively. UnitedHealthcare's market leadership position enables it to negotiate favorable terms with healthcare providers and develop innovative insurance products that meet evolving consumer needs.
Optum delivers comprehensive healthcare services and technology solutions through three main segments that support the entire healthcare ecosystem:
Optum Health provides direct patient care and health services, operating clinics, surgical centers, and home health services. The segment employs healthcare professionals including physicians, nurses, and care coordinators who deliver integrated care to patients across various settings. Optum Health focuses on value-based care models that align financial incentives with health outcomes, creating more efficient and effective healthcare delivery systems.
Optum Insight offers data analytics, consulting, and technology services to healthcare organizations, payers, and life sciences companies. The segment leverages UnitedHealth Group's vast healthcare data assets to provide insights that improve clinical outcomes, reduce costs, and enhance operational efficiency. Optum Insight's services include population health management, revenue cycle optimization, and healthcare technology implementation.
Optum Rx manages pharmacy benefits for millions of people, negotiating with pharmaceutical manufacturers and managing prescription drug programs. In 2025, Optum Rx achieved 15% revenue growth, demonstrating strong performance in the pharmacy benefits management market. The segment combines purchasing power with clinical expertise to optimize medication therapy, improve adherence, and manage drug costs effectively.
UnitedHealth Group's integrated business model creates significant competitive advantages. The company's ability to combine insurance coverage with direct healthcare delivery enables better care coordination, improved health outcomes, and more efficient resource utilization. This integration also provides valuable data insights that inform product development, care management programs, and operational improvements.
In 2025, UnitedHealth Group demonstrated exceptional financial performance with consolidated revenues of $447.6 billion, representing 12% growth year-over-year. The company's adjusted earnings from operations reached $21.7 billion, reflecting strong operational execution despite challenges including cyberattack-related costs and business restructuring charges.
In Q2 2026, UnitedHealth Group reported revenues of $112.0 billion and earnings from operations of $8.0 billion, with net margin of 4.9%. Cash flows from operations were $11.1 billion, or 1.9 times net income. UnitedHealthcare served 48.5 million consumers (down from 49.8 million in 2025) and reported Q2 2026 revenues of $86.0 billion with earnings of $3.9 billion. Optum supported over 120 million consumers and generated Q2 2026 revenues of $65.7 billion with earnings of $4.0 billion, representing 160 basis points of margin expansion year over year.
The company's financial metrics demonstrate operational efficiency and strong cash generation. UnitedHealth Group achieved cash flows from operations of $19.7 billion in 2025, representing 1.5 times net income. The company maintains a debt-to-capital ratio of 41.2% (as of June 30, 2026) and targets a long-term ratio of 40.0%, reflecting prudent financial management.
UnitedHealth Group employs approximately 440,000 people worldwide, making it one of the largest employers in the healthcare industry. The company's workforce includes healthcare professionals, technology specialists, data analysts, and business professionals who support the company's integrated healthcare delivery model.
Looking toward 2026, UnitedHealth Group initially established revenue guidance greater than $439.0 billion (a 2% decline reflecting divestitures and membership reduction) and adjusted earnings outlook greater than $17.75 per share. After strong Q2 2026 results, the company raised its full-year 2026 guidance to adjusted net earnings of $19.50 to $20.00 per share, with earnings from operations greater than $25.2 billion. The company expects operating earnings from UnitedHealthcare to exceed $12 billion, Optum Health to exceed $2.2 billion, Optum Insight to exceed $4.9 billion, and Optum Rx to exceed $6.25 billion. Cash flows from operations are expected to be approximately $24 billion, with share repurchases of at least $5 billion.
Optum Health operates within UnitedHealth Group's corporate responsibility framework. As one of the largest healthcare delivery organizations in the United States, Optum Health's sustainability and ethics considerations center on healthcare accessibility, environmental responsibility, ethical clinical practices, and data security.
UnitedHealth Group has committed to reducing carbon emissions by 30 percent by 2030 and achieving carbon neutrality by 2040. Optum Health facilities participate in these environmental initiatives through energy-efficient medical equipment, renewable energy sources where available, and waste management systems. The company's telehealth services reduce patient travel emissions, and its electronic health records minimize paper usage.
Optum Health's value-based care model aligns with sustainability principles by reducing unnecessary medical procedures, minimizing hospital readmissions, and optimizing treatment pathways. The focus on preventive care and care coordination can improve patient outcomes while reducing the environmental footprint of healthcare delivery.
Optum Health supports community health initiatives that improve healthcare access and outcomes in underserved communities. The company operates community health centers, mobile health clinics, and partnerships with local organizations to address healthcare disparities. These programs include health education initiatives, preventive care screenings, and support for social determinants of health.
Optum Health maintains ethical standards for clinical decision-making, patient privacy, and healthcare delivery. The company's ethical framework emphasizes evidence-based medicine, patient-centered care, and transparent communication about treatment options and costs. Optum Health physicians operate with clinical autonomy while adhering to ethical guidelines that prioritize patient welfare over financial considerations.
Optum Health is not certified as a B Corporation. The brand does not carry independent sustainability certifications. Sustainability and ethics claims are primarily tied to UnitedHealth Group's broader corporate responsibility programs and the inherent social benefit of providing healthcare services to patients.
Optum Health has been recognized by healthcare industry organizations for its leadership in implementing value-based care models and demonstrating improved patient outcomes through coordinated care delivery. The company's approaches to managing patient populations and reducing healthcare costs while maintaining quality have received acknowledgment from healthcare quality organizations and industry publications.
Optum Health's integration of healthcare technology, data analytics, and digital health solutions has received recognition from healthcare technology organizations. The company's use of predictive analytics and telehealth platforms to improve care coordination and patient outcomes has been acknowledged in healthcare industry analyses.
Optum Health's physician practices and clinical facilities have received awards for clinical quality, patient safety, and care coordination excellence from healthcare quality improvement organizations, patient satisfaction surveys, and clinical accreditation bodies.
Optum Health has been recognized as an employer of choice in the healthcare industry, particularly for physicians and clinical professionals. The company's compensation packages, professional development opportunities, and work environment have received acknowledgment from healthcare professional organizations and employment rating agencies.
Optum Health's community health initiatives and partnerships with local organizations have received recognition for improving healthcare access and addressing health disparities in underserved communities. The company's community engagement programs, mobile health clinics, and preventive care initiatives have been acknowledged by public health organizations.
Optum Health's integration with UnitedHealth Group's insurance operations has faced significant antitrust scrutiny from regulators and consumer advocacy groups. Critics argue that UnitedHealth Group's simultaneous ownership of the nation's largest health insurer (UnitedHealthcare) and one of its largest physician employers (Optum Health) creates conflicts of interest and may reduce competition in healthcare markets. The Department of Justice has increased scrutiny of UnitedHealth Group's vertical integration strategy, including its acquisition of physician practices through Optum Health.
Optum Health has faced criticism regarding physician referral patterns and potential incentives for Optum-employed physicians to refer patients to UnitedHealth Group-affiliated facilities and services. Some investigations have examined whether Optum Health's integrated structure creates financial incentives that influence clinical decision-making, potentially compromising patient care quality or increasing healthcare costs.
The February 2024 Change Healthcare ransomware attack, which affected an Optum subsidiary, disrupted healthcare payments across the United States and highlighted the cybersecurity risks associated with UnitedHealth Group's extensive healthcare data infrastructure. While Optum Health's clinical systems were not directly compromised, the attack raised concerns about data security across the Optum platform and the potential vulnerability of patient health information.
Optum Health has faced investigations and legal actions related to billing practices, coding accuracy, and reimbursement claims. Some cases have examined whether Optum Health's billing practices comply with healthcare regulations and whether the company has appropriately documented and billed for medical services provided to patients.
Optum Health's dominant market position and rapid expansion through physician practice acquisitions have raised concerns about reduced competition in local healthcare markets. Smaller healthcare providers and independent physician groups have struggled to compete with Optum Health's scale and resources, leading to consolidation trends in the healthcare industry. The American Medical Association and other physician organizations have expressed concerns about the impact of corporate ownership of physician practices on physician autonomy and patient care.
Despite Optum Health's focus on value-based care and quality improvement, some critics have questioned whether the company's integrated structure and emphasis on cost containment negatively impacts patient care quality. Investigations have examined whether financial incentives in Optum Health's business model appropriately balance cost control with patient care quality and access.
UnitedHealth Group's market power has attracted attention from federal antitrust regulators. In 2024 and 2025, the Department of Justice investigated UnitedHealth Group's acquisition strategy and vertical integration model. This regulatory scrutiny creates uncertainty about Optum Health's ability to make future acquisitions or expand its physician network through acquisitions.
No direct competitors found in the same category. This could be because Optum Healthoperates in a unique market segment or we're still building our competitor database.
Looking for brands with different ownership structures? These similar brands are not owned by UnitedHealth Group, giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsOwned by Chempro Chemists
Australian online pharmacy operated by Chempro Chemists from Molendinar, Queensland. Offers prescription medications, health products, and wellness items through digital platforms and mail-order delivery.
Pharmacy Direct is privately owned, unlike Optum Health which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by EKR Therapeutics, Inc.
Retavase (reteplase) is a prescription thrombolytic medication indicated for acute ST-elevation myocardial infarction. Administered as two 10-unit intravenous bolus injections 30 minutes apart. Currently marketed by Chiesi USA.
Retavase is privately owned, unlike Optum Health which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by IBSA Institut Biochimique S.A.
IBSA Institut Biochimique SA's branded levothyroxine softgel capsule (Tirosint) and liquid solution (Tirosint-SOL), FDA approved for hypothyroidism, formulated without dyes, gluten, lactose, alcohol, or sugar, providing an excipient-free alternative to conventional levothyroxine tablets for patients with sensitivities or absorption issues.
Tirosint is privately owned, unlike Optum Health which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Alcon Inc.
Independent publicly traded global eye care company headquartered in Geneva, Switzerland, specializing in surgical equipment, contact lenses, and ophthalmic products. Spun off from Novartis in April 2019.
Alcon operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by Bausch + Lomb Corporation
Global eye health company and contact lens manufacturer founded in 1853, known for ULTRA, Biotrue One Day, and INFUSE lens lines. Public on NYSE and TSX under BLCO.
Bausch + Lomb operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by GE HealthCare Technologies Inc.
Independent publicly traded healthcare technology company spun off from General Electric in January 2023, providing medical imaging, diagnostics, and healthcare IT solutions globally.
GE HealthCare operates independently without a large parent corporation.
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.

Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.

Prescription isotretinoin brand developed by Roche and approved by the FDA in 1982 for severe nodular acne. Roche discontinued the brand name in the United States in 2009; the drug continues as Roaccutane in international markets.

Activase (alteplase) is a prescription thrombolytic medication manufactured by Genentech, a wholly-owned subsidiary of Roche. Used to treat acute ischemic stroke, heart attack, and pulmonary embolism.